SCHEMBL16696176

SCHEMBL16696176

CC(C)n1c2ccc(N3c4ccccc4Oc4ccccc43)cc2c2cc(N3c4ccccc4Oc4ccccc43)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ P2RX4 Q99571 9/20 0.38
▸ NPY5R Q15761 4/20 0.35
▸ BCHE P06276 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ RORA P35398 1/20 0.33
▸ RORC P51449 1/20 0.33
▸ RORB Q92753 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ P2RX1 P51575 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ CASP7 P55210 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16696175 0.96 MEN1 (0.46) MEN1KMT2AP2RX4NPY5RBCHE
SCHEMBL21514265 0.85 MEN1 (0.40) MEN1KMT2AP2RX4NPY5RBCHE
SCHEMBL21324366 0.85 MEN1 (0.40) MEN1KMT2AP2RX4NPY5RBCHE
SCHEMBL18136553 0.83 GPR3 (0.38) MEN1KMT2AP2RX4BCHEACHE
SCHEMBL12117309 0.81 KDM4E (0.36) MEN1KMT2AP2RX4BCHEACHE
SCHEMBL18056702 0.79 GPR3 (0.47) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL17381254 0.79 KDM4E (0.44) MEN1KMT2AP2RX4MAPTSMN1; SMN2
SCHEMBL6123861 0.79 L3MBTL1 (0.43) MEN1KMT2AP2RX4SMN1; SMN2TSHR
SCHEMBL12117311 0.77 L3MBTL1 (0.41) MEN1KMT2AP2RX4SMN1; SMN2TSHR
SCHEMBL17381320 0.76 MAPT (0.51) MEN1KMT2ANPY5RMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160301015-A1 LIGHT-EMITTING COMPOUNDS FOR LIGHT-EMITTING DEVICES NITTO DENKO CORPORATION (JP) 2016-10-13 — — US disclosed
WO-2016138077-A1 GAS SENSOR ELEMENT NITTO DENKO CORPORATION (JP) 2016-09-01 — — WO disclosed
WO-2015066354-A1 LIGHT-EMITTING COMPOUNDS FOR LIGHT-EMITTING DEVICES NITTO DENKO CORPORATION (JP) 2015-05-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160301015-A1 LIGHT-EMITTING COMPOUNDS FOR LIGHT-EMITTING DEVICES CRY1, ALDH1A2, CRY2 MEN1 1782/4885KMT2A 3169/4885P2RX4 2023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback